Biochemistry Department, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt.
Bioorg Chem. 2020 Aug;101:103932. doi: 10.1016/j.bioorg.2020.103932. Epub 2020 May 23.
There is an urging continuous need for novel anti-cancer agents due to persistent chemoresistance. Herein, newly synthesized cinnolines are evaluated for their possible anticancer activities and suggested mechanisms. In the current study, a simple and efficient synthesis of densely functionalized cinnolines has been developed that relied on multi-component reaction of ethyl 5-cyano-4-methyl-1-aryl-6-oxo-1,6-dihydropyridazine-3-carboxylates with aromatic aldehydes and nitromethane in dioxane/pipridine under controlled microwave heating. Selected cinnolines (4a-c, e, h, j-n, q-v) were tested for possible anticancer activity using in vitro one dose assay at National Cancer institute, USA. Only cinnoline 4b stood out as the most potent cinnoline derivative (mean GI%=26.33) with broad-spectrum antitumor activity against the most tested cancer cell lines from all subpanels. The target cinnoline 4b emerged as the most active derivative against both leukemia RPMI-8226 and melanoma LOX IMVI cell lines (GI% = 106.06 and 82.1) respectively, with IC values equal to 17.12 ± 1.31 and 12.32 ± 0.75 μg/mL, which are comparable to those of staurosporin; 24.97 ± 1.47 and 8.45 ± 0.42 μg/mL, respectively. Cinnoline 4b influenced cell cycle distribution causing pre-G1 apoptosis and cell growth arrest at G2/M phase. It also induced apoptosis in both cell lines as manifested by significant increase in the percent of annexin V-FITC positive apoptotic cells in leukemia RPMI-8226 cells (from 1.09% to 12.47%) and melanoma LOX IMVI (from 1.32% to 19.05%). In addition, it showed lower expression levels of anti-apoptotic Bcl-2 protein, and higher expression levels of pro-apoptotic proteins; Bax, p53, cytochrome c, caspases 3 and 9. CONCLUSION: Induction of mitochondrial intrinsic pathway of apoptosis is a possible mechanism by which cinnoline 4b may confer its anticancer activity.
由于持续的化疗耐药性,人们迫切需要新型抗癌药物。本文评价了新合成的肉桂啶的可能抗癌活性及其作用机制。在本研究中,开发了一种简单高效的合成方法,该方法依赖于多组分反应,即乙基 5-氰基-4-甲基-1-芳基-6-氧代-1,6-二氢嘧啶-3-羧酸酯与芳香醛和硝甲烷在二氧六环/哌啶中在微波控制下加热。选择的肉桂啶(4a-c、e、h、j-n、q-v)在美国国立癌症研究所进行了体外单剂量测定,以检测其可能的抗癌活性。只有肉桂啶 4b 脱颖而出,成为最有效的肉桂啶衍生物(平均 GI%=26.33),对来自所有亚组的大多数测试癌细胞系具有广谱抗肿瘤活性。目标肉桂啶 4b 对白血病 RPMI-8226 和黑色素瘤 LOX IMVI 细胞系的活性最高(GI%=106.06 和 82.1),IC 值分别为 17.12±1.31 和 12.32±0.75μg/mL,与司莫司汀相当;分别为 24.97±1.47 和 8.45±0.42μg/mL。肉桂啶 4b 影响细胞周期分布,导致 G1 期前凋亡和 G2/M 期细胞生长停滞。它还诱导两种细胞系中的细胞凋亡,表现为白血病 RPMI-8226 细胞中 Annexin V-FITC 阳性凋亡细胞的百分比显著增加(从 1.09%增加到 12.47%)和黑色素瘤 LOX IMVI(从 1.32%增加到 19.05%)。此外,它显示出较低的抗凋亡 Bcl-2 蛋白表达水平和较高的促凋亡蛋白;Bax、p53、细胞色素 c、caspase 3 和 9。结论:诱导线粒体内在凋亡途径可能是肉桂啶 4b 发挥抗癌活性的机制之一。